These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16836727)

  • 1. Heart rate variability.
    Bilchick KC; Berger RD
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):691-4. PubMed ID: 16836727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
    Popov VV; Kopitsa NP; Oparin AL
    Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart rate variability in myocardial infarction and heart failure.
    Chattipakorn N; Incharoen T; Kanlop N; Chattipakorn S
    Int J Cardiol; 2007 Sep; 120(3):289-96. PubMed ID: 17349699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
    Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of statin therapy on circadian variation of acute myocardial infarction.
    Erdoğan D; Ozaydın M; Türker Y; Karabacak M; Varol E; Doğan A
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):429-33. PubMed ID: 20929700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of third-generation beta-adrenergic receptor blockers.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S40-3. PubMed ID: 2481790
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin therapy in heart failure: prognostic effects and potential mechanisms.
    Shanes JG; Minadeo KN; Moret A; Groner M; Tabaie SA
    Am Heart J; 2007 Oct; 154(4):617-23. PubMed ID: 17892981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dangers of skipping medications after a heart attack.
    Harv Heart Lett; 2008 May; 18(9):7. PubMed ID: 18655307
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart rate variability measurements and the prediction of ventricular arrhythmias.
    Reed MJ; Robertson CE; Addison PS
    QJM; 2005 Feb; 98(2):87-95. PubMed ID: 15671474
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart-rate reduction and beta-blockade in early post-infarction cardiac remodelling.
    Goldstein RE; Haigney MC
    Cardiovasc Res; 2008 Jul; 79(1):5-6. PubMed ID: 18487234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of drug therapy of myocardial infarction on the inflammatory process].
    Chukaeva II; Orlova NV; Khavka NN
    Voen Med Zh; 2007 Jul; 328(7):38-40. PubMed ID: 17902343
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart rate is a simplistic marker of mortality in acute myocardial infarction.
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 May; 8(3):197-9. PubMed ID: 10228662
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of atenolol or metoprolol on waking hour dynamics of the QT interval in myocardial infarction.
    Singh JP; Musialek P; Sleight P; Davey P; Marinho M; Hart G
    Am J Cardiol; 1998 Apr; 81(7):924-6. PubMed ID: 9555785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

  • 16. Tako-tsubo syndrome associated with sexual intercourse.
    Tomcsányi J; Marosi A; Arabadzisz K; Zsoldos A; Bózsik B
    Int J Cardiol; 2007 Oct; 121(3):e28-9. PubMed ID: 17884207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
    Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
    Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in heart failure.
    Deedwania PC; Javed U
    Cardiol Clin; 2008 Nov; 26(4):573-87. PubMed ID: 18929232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in heart rate turbulence as a measure of response to beta-blocker therapy for heart failure.
    Saxon LA
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):757-8. PubMed ID: 15250857
    [No Abstract]   [Full Text] [Related]  

  • 20. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
    Carvalho VO
    Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.